Therapeutic Goods (Permissible Indications) Determination (No. 1) 2021 (Cth)

Therapeutic Goods (Permissible Indications) Determination (No. 1) 2021

I, Adam Cook, as delegate of the Minister for Health, make the following determination.

Dated 19 January 2021

Adam Cook Acting Assistant Secretary Complementary and Over the Counter Medicines Branch Health Products Regulation Group Department of Health

Contents 1 Name 2 Commencement 3 Authority 4 Definitions 5 Permissible indications 6 Requirements in relation to permissible indications 7 Repeals Schedule 1—Specified permissible indications and requirements applying to these indications when contained in a medicine Table 1—Indications relating to general health or body parts

Table 2—Indications relating to bone

Table 3—Indications relating to the cardiovascular system

Table 4—Indications relating to the endocrine system 29

Table 5—Indications relating to the gastrointestinal system

Table 6—Indications relating to the immune system 44

Table 7—Indications relating to muscles 46

Table 8—Indications relating to the nervous system 49

Table 9—Indications relating to nutrition 55

Table 10—Indications relating to the reproductive system 58

Table 11—Indications relating to the respiratory system

Table 12—Indications relating to skin 75

Table 13—Indications relating to the urinary system 82

Table 14—Traditional Chinese medicine indications 84

Table 15—Traditional Ayurvedic medicine indications 108

Schedule 2—Repeals 120 Therapeutic Goods (Permissible Indications) Determination (No.2) 2019 120

1 Name This instrument is the Therapeutic Goods (Permissible Indications) Determination (No. 1) 2021.

2 Commencement

(1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.